Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1α

Piceatannol (PIC) is known to have anticancer activity, which has been attributed to its ability to block the proliferation of cancer cells via suppression of the NF-kB signaling pathway. However, its effect on hypoxia-inducible factor (HIF) is not well known in cancer. In this study, PIC was loaded...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Cancers (Basel)
Main Authors: A. A. Aljabali, Alaa, A. Bakshi, Hamid, L. Hakkim, Faruck, Haggag, Yusuf A., M. Al-Batanyeh, Khalid, S. Al Zoubi, Mazhar, Al-Trad, Bahaa, M. Nasef, Mohamed, Satija, Saurabh, Mehta, Meenu, Pabreja, Kavita, Mishra, Vijay, Khan, Mohammed, Abobaker, Salem, M. Azzouz, Ibrahim, Dureja, Harish, M. Pabari, Ritesh, Ali K. Dardouri, Ashref, Kesharwani, Prashant, Gupta, Gaurav, Dhar Shukla, Shakti, Prasher, Parteek, B. Charbe, Nitin, Negi, Poonam, N. Kapoor, Deepak, Chellappan, Dinesh Kumar, Webba da Silva, Mateus, Thompson, Paul, Dua, Kamal, McCarron, Paul, M. Tambuwala, Murtaza
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI 2020
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7017258/
https://ncbi.nlm.nih.gov/pubmed/31906321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010113
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים